GlassScriptPhysician profile
Derrick Chate Wansom
NPI 1306124912
$14,852.25
in general payments reported to CMS, 2019-2025
23 companies · $1,431 in 2025
The $1,431 reported for 2025 was more than what 75% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,618 · 2020: $655 · 2021: $2,788 · 2022: $4,332 · 2023: $1,606 · 2024: $1,423 · 2025: $1,431.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,460.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,613.12 | 2019-2025 | Proclaim, Octrode, Eterna |
| Vertiflex, INC. | $1,918.87 | 2019 | |
| Nevro Corp. | $1,661.99 | 2019-2022 | |
| Boston Scientific Corporation | $1,521.26 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Globus Medical, INC. | $731.66 | 2025 | Senza, Omnia, Vyrsa V1 |
| Foundation Fusion Solutions, LLC | $659.92 | 2021-2023 | |
| Spinal Simplicity, LLC | $630.25 | 2021-2025 | Ha Minuteman G3-R |
| Painteq LLC | $530.60 | 2022-2024 | Painteq |
| Si-Bone, INC. | $410.09 | 2019-2025 | |
| Medtronic, INC. | $292.20 | 2022-2025 | Intellis Adaptivestim, Primeadvanced Surescan, Vanta Adaptivestim |
| Nalu Medical, INC. | $242.89 | 2021-2024 | Nalu Neurostimulation System |
| Relievant Medsystems, INC. | $228.00 | 2022 | |
| Bioventus LLC | $128.60 | 2022-2025 | Gelsyn-3, Xcell |
| Biohaven Pharmaceuticals, INC. | $71.03 | 2021 | |
| Spr Therapeutics, INC | $52.40 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $28.42 | 2022 | |
| Pacira Therapeutics, INC. | $27.70 | 2019-2021 | |
| Averitas Pharma INC. | $23.70 | 2023 | Qutenza |
| Depuy Synthes Sales INC. | $22.47 | 2025 | Monovisc, Orthovisc |
| Amgen INC. | $20.93 | 2019 | |
| Biodelivery Sciences International, INC. | $13.52 | 2019 | |
| Scilex Pharmaceuticals INC. | $11.70 | 2019 | |
| Daiichi Sankyo INC. | $10.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derrick Wansom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.